Dulaglutide slows kidney disease in type 2 diabetes
Abstract
Hertzel Gerstein and colleagues1Gerstein HC Colhoun HM Dagenais GR et al.Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.Lancet. 2019; 394: 131-138Summary Full Text Full Text PDF PubMed Scopus (252) Google Scholar reported the renal outcomes of the REWIND study, a randomised, placebo-controlled trial of dulaglutide in type 2 diabetes. We would like to make some...
Paper Details
Title
Dulaglutide slows kidney disease in type 2 diabetes
Published Date
Feb 1, 2020
Journal
Volume
395
Issue
10224
Pages
559 - 559
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History